| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,998 | 18,049 | 19,072 | 23,052 | | Cost of Revenue | 10,769 | 9,107 | 9,662 | 11,424 | | | Gross Profit | 10,229 | 8,942 | 9,410 | 11,628 | | | Operating Expenses | | Research Development | 1,074 | 1,089 | 999 | 881 | | Selling General and Administrative | 6,724 | 6,240 | 5,689 | 6,724 | | Non Recurring | 59 | 422 | 27 | (25) | | Others | 442 | 386 | 344 | 466 | | | | Total Operating Expenses | 8,299 | 8,137 | 7,059 | 8,046 | | | | Operating Income or Loss | 1,930 | 805 | 2,351 | 3,582 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (386) | (424) | 136 | (937) | | Earnings Before Interest And Taxes | 1,544 | 381 | 2,487 | 2,645 | | Interest Expense | 60 | 34 | 45 | 72 | | Income Before Tax | 1,484 | 347 | 2,442 | 2,573 | | Income Tax Expense | 163 | 66 | 603 | 866 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,321 | 281 | 1,839 | 1,707 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 369 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,321 | 281 | 1,839 | 2,076 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,321 | $281 | $1,839 | $2,076 |
|
0.03% Nasdaq 0.00%
Income Statement
